A TNF-α related peptide W9 inhibits the soluble RANKL-induced osteoclastogenesis stronger than the membrane-bound RANKL-induced osteoclast formation

被引:0
|
作者
Aoki, K
Suzuki, Y
Horie, D
Ohya, K
机构
[1] Tokyo Med & Dent Univ, Grad Sch, Pharmacol Sect, Tokyo 1138549, Japan
[2] Tokyo Med & Dent Univ, Grad Sch, Sect Periodontol, Tokyo 1138549, Japan
来源
JAPANESE JOURNAL OF PHARMACOLOGY | 2002年 / 88卷
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P183
引用
收藏
页码:107P / 107P
页数:1
相关论文
共 50 条
  • [21] A brain-specific chemokine, FAM19A5 inhibits RANKL-induced osteoclast formation
    Park, MinYoung
    Lee, Ha Young
    Kim, Hyeung Sik
    Lee, Mingyu
    Kim, Ye Seon
    Seong, Jae Young
    Bae, Yoe-Sik
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [22] A Synthetic Peptide, CK2.3, Inhibits RANKL-Induced Osteoclastogenesis through BMPRIa and ERK Signaling Pathway
    Nguyen, John
    Kelly, Semaj
    Wood, Ryan
    Heubel, Brian
    Nohe, Anja
    JOURNAL OF DEVELOPMENTAL BIOLOGY, 2020, 8 (03)
  • [23] Eleutherococcus senticosus Inhibits RANKL-induced osteoclast formation by attenuating the NF-κB and MAPKs signaling pathway
    Yang, Xiaobin
    Chang, Zhen
    Ma, Rui
    Guo, Hua
    Zhao, Qingpeng
    Wang, Xiaodong
    Kong, Lingbo
    Hao, Dingjun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (04): : 4514 - 4521
  • [24] Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-κB and Akt pathways
    Hu, Jin-Ping
    Nishishita, Kazuhisa
    Sakai, Eiko
    Yoshida, Hajime
    Kato, Yuzo
    Tsukuba, Takayuki
    Okamoto, Kuniaki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 580 (1-2) : 70 - 79
  • [25] 3′4′7-Trihydroxyflavone inhibits RANKL-induced osteoclast formation via NFATc1
    Kang, Ju-Hee
    Lee, Juhyun
    Moon, Miran
    Yim, Mijung
    PHARMAZIE, 2015, 70 (10): : 661 - 667
  • [26] FAM19A5, a brain-specific chemokine, inhibits RANKL-induced osteoclast formation through formyl peptide receptor 2
    Min Young Park
    Hyung Sik Kim
    Mingyu Lee
    Byunghyun Park
    Ha Young Lee
    Eun Bee Cho
    Jae Young Seong
    Yoe-Sik Bae
    Scientific Reports, 7
  • [27] Crocin inhibits RANKL-induced osteoclast formation and bone resorption by suppressing NF-κB signaling pathway activation
    Fu, Lijia
    Pan, Fang
    Jiao, Yong
    IMMUNOBIOLOGY, 2017, 222 (04) : 597 - 603
  • [28] Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo
    Zhu, Xiang
    Gao, Jun J.
    Landao-Bassonga, Euphemie
    Pavlos, Nathan J.
    Qin, An
    Steer, James H.
    Zheng, Ming H.
    Dong, Yang
    Cheng, Tak S.
    BIOCHEMICAL PHARMACOLOGY, 2016, 104 : 118 - 130
  • [29] FAM19A5, a brain-specific chemokine, inhibits RANKL-induced osteoclast formation through formyl peptide receptor 2
    Park, Min Young
    Kim, Hyung Sik
    Lee, Mingyu
    Park, Byunghyun
    Lee, Ha Young
    Cho, Eun Bee
    Seong, Jae Young
    Bae, Yoe-Sik
    SCIENTIFIC REPORTS, 2017, 7
  • [30] RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis
    Ishii, Masaru
    Saeki, Yukihiko
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S193 - S193